Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
CAM is stocked at 467 licensed dispensaries across California, New York, and Illinois, 431 of them in California, with the deepest coverage in Los Angeles, San Diego, Sacramento, Santa Ana, and Costa Mesa. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, CAM’s mix concentrated further into Flower at 79.50% share, up alongside a 41.95% year-over-year lift and a 3.52% month-over-month gain, while Pre-Roll expanded to 18.85% share with 143.85% year-over-year growth and 11.48% month-over-month growth. Smaller lines moved the other way: Edible held 1.31% share with 25.68% year-over-year growth but a 7.96% month-over-month decline, and Vapor Pens contracted to 0.34% share with an 84.02% year-over-year drop and a 39.65% month-over-month decline. With overall brand sales up 49.47% year over year and average price down 19.22%, the pattern implies volume-led gains concentrated in Flower and Pre-Roll while higher-price or under-scaled formats recede.
This mix shift positions CAM as a Flower-first brand with a scaling Pre-Roll engine, evidenced by a rank of 2 in Flower in California and a combined 98.35% share across Flower and Pre-Roll. The widening gap between growing Flower (+41.95% YoY, +3.52% MoM) and shrinking Vapor Pens (−84.02% YoY, −39.65% MoM), alongside a brand-wide price decrease of 19.22%, suggests a deliberate trade-down in price points within core inhalables to capture volume. The thesis is that CAM’s near-term growth will be anchored by depth in Flower and adjacent Pre-Rolls, prioritizing velocity and rank in core inhalables over diversification into Edibles or Vapor Pens.
Competitive Landscape
CAM is ranked #2 in CA Flower in October 2026, up 1 place from #3 year over year, while holding #2 over the last three months and peaking at #1 in August 2026; this contrasts with STIIIZY at #1 now from #2 a year ago and with CannaBiotix (CBX) sliding from #1 to #3 on a -16.6% YoY sales change. Compared with Oakfruitland vaulting from #11 to #4 on 109.1% YoY growth and Allswell moving from #4 to #5 on 31.2% YoY growth, CAM’s ascent from #3 to #1 in August 2026 and retention of #2 through October 2026 indicates a mid-year surge that stabilized into a top-two position despite accelerating challenger momentum below; the trajectory implies CAM is consolidating share at the top while needing incremental gains to overtake a faster-rising #1.
Notable Products
CAM leans heavily on new launches in October 2026, with products first sold in the last six months generating 28.0% of sales and one of them, Agent Orange (7g), already in the top lineup. That newness footprint is larger than the 22.8% captured by the entire top 10, so a sizeable share of sales comes from recently added items rather than a few long-running staples.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






